All Stories

  1. Gasotransmitters and noble gases in cardioprotection: unraveling molecular pathways for future therapeutic strategies
  2. Reperfusion Injury in Patients With Acute Myocardial Infarction
  3. Enhancing Heart Transplantation: Utilizing Gas-Loaded Nanocarriers to Mitigate Cold/Hypoxia Stress
  4. Expanding the Frontiers of Guardian Antioxidant Selenoproteins in Cardiovascular Pathophysiology
  5. Enhancing Vitamin D3 Efficacy: Insights from Complexation with Cyclodextrin Nanosponges and Its Impact on Gut–Brain Axes in Physiology and IBS Syndrome
  6. Clinical Applications for Gasotransmitters in the Cardiovascular System: Are We There Yet?
  7. Inhibitors of NLRP3 Inflammasome in Ischemic Heart Disease: Focus on Functional and Redox Aspects
  8. Oxygen Nanocarriers for Improving Cardioplegic Solution Performance: Physico-Chemical Characterization
  9. Platelets and Cardioprotection: The Role of Nitric Oxide and Carbon Oxide
  10. Ischemic Conditioning to Reduce Fatigue in Isometric Skeletal Muscle Contraction
  11. Developing New Cyclodextrin-Based Nanosponges Complexes to Improve Vitamin D Absorption in an In Vitro Study
  12. Pathways for Cardioprotection in Perspective: Focus on Remote Conditioning and Extracellular Vesicles
  13. Electrocardiogram
  14. Arterial Pressure
  15. Pulmonary Circulation
  16. Lymphatic Circulation
  17. HNO Protects the Myocardium against Reperfusion Injury, Inhibiting the mPTP Opening via PKCε Activation
  18. Do the Current Guidelines for Heart Failure Diagnosis and Treatment Fit with Clinical Complexity?
  19. A TRICk to Improve the Effectiveness of RIC: Role of Limb Temperature in Enhancing the Effectiveness of Remote Ischemic Conditioning
  20. Regulation of STAT3 and its role in cardioprotection by conditioning: focus on non-genomic roles targeting mitochondrial function
  21. Percutaneous Coronary Intervention (PCI) Reprograms Circulating Extracellular Vesicles from ACS Patients Impairing Their Cardio-Protective Properties
  22. Cyclic Nigerosyl-Nigerose as Oxygen Nanocarrier to Protect Cellular Models from Hypoxia/Reoxygenation Injury: Implications from an In Vitro Model
  23. Extracellular Vesicles in Comorbidities Associated with Ischaemic Heart Disease: Focus on Sex, an Overlooked Factor
  24. The Inflammatory Cytokine IL-3 Hampers Cardioprotection Mediated by Endothelial Cell-Derived Extracellular Vesicles Possibly via Their Protein Cargo
  25. Is macrophages heterogeneity important in determining COVID-19 lethality?
  26. Sex‐related differences in COVID‐19 lethality
  27. Diabetic Cardiomyopathy and Ischemic Heart Disease: Prevention and Therapy by Exercise and Conditioning
  28. Effect of hyperglycaemia and diabetes on acute myocardial ischaemia–reperfusion injury and cardioprotection by ischaemic conditioning protocols
  29. Obesity and Cardioprotection
  30. From Molecular Mechanisms to Clinical Management of Antineoplastic Drug-Induced Cardiovascular Toxicity: A Translational Overview
  31. Cardioprotection of PLGA/gelatine cardiac patches functionalised with adenosine in a large animal model of ischaemia and reperfusion injury: A feasibility study
  32. Hemodynamic abnormalities during muscle metaboreflex activation in patients with type 2 diabetes mellitus
  33. Circulating blood cells and extracellular vesicles in acute cardioprotection
  34. Innate immunity as a target for acute cardioprotection
  35. Role of NLRP-3 Inflammasome in Hypertension: A Potential Therapeutic Target
  36. Editorial: Redox and Nitrosative Signaling in Cardiovascular System: From Physiological Response to Disease
  37. Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection
  38. Cardioprotective Properties of Human Platelets Are Lost in Uncontrolled Diabetes Mellitus: A Study in Isolated Rat Hearts
  39. Silica nanoparticles actively engage with mesenchymal stem cells in improving acute functional cardiac integration
  40. Notch1 Mediates Preconditioning Protection Induced by GPER in Normotensive and Hypertensive Female Rat Hearts
  41. Metaflammation: Tissue-Specific Alterations of the NLRP3 Inflammasome Platform in Metabolic Syndrome
  42. Editorial: Alteration of Redox Equilibrium, Inflammation and Progression of Disease
  43. Mitochondria in Cardiac Postconditioning
  44. Redox Aspects of Chaperones in Cardiac Function
  45. Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective
  46. α-Cyclodextrin and α-Cyclodextrin Polymers as Oxygen Nanocarriers to Limit Hypoxia/Reoxygenation Injury: Implications from an In Vitro Model
  47. Apelin-induced cardioprotection against ischaemia/reperfusion injury: roles of epidermal growth factor and Src
  48. Obestatin regulates cardiovascular function and promotes cardioprotection through the nitric oxide pathway
  49. Cardioprotective effects of calcitonin gene-related peptide in isolated rat heart and in H9c2 cells via redox signaling
  50. Platelets, diabetes and myocardial ischemia/reperfusion injury
  51. Nanoprecipitated catestatin released from pharmacologically active microcarriers (PAMs) exerts pro-survival effects on MSC
  52. Myocardial ischemia/reperfusion upregulates the transcription of the Neuregulin1 receptor ErbB3, but only postconditioning preserves protein translation: Role in oxidative stress
  53. role of hypertension, hypertrophy and therapy in conditioning ischemia reperfusion injury
  54. Pathophysiology of anthracycline cardiotoxicity
  55. A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity
  56. A recommended practical approach to the management of target therapy and angiogenesis inhibitors cardiotoxicity
  57. Editorial (Thematic Issue: Protection, Repair and Regeneration of Achybreaky Heart)
  58. Endogenous Cardioprotective Agents: Role in Pre and Postconditioning
  59. A man is as young as his endothelium
  60. Preconditioning cardioprotection and exercise performance: a radical point of view
  61. Redox signalling and cardioprotection: translatability and mechanism
  62. cardioprotection by exercise
  63. Redox balance and cardioprotection
  64. The switch from protective signalling to deleterious oxidative/nitrosative/nitrative stress
  65. Mitochondrial Pathways, Permeability Transition Pore, and Redox Signaling in Cardioprotection: Therapeutic Implications
  66. Cardiac Postconditioning
  67. Cardioprotective Pathways During Reperfusion: Focus on Redox Signaling and Other Modalities of Cell Signaling
  68. Cardioprotection: A radical view
  69. Intermittent Adenosine at the Beginning of Reperfusion Does Not Trigger Cardioprotection
  70. Protective effect of hydrogen sulfide against oxidative stress of myoblasts
  71. Nitric Oxide Synthase Function in Exercise
  72. Postconditioning and intermittent bradykinin induced cardioprotection require cyclooxygenase activation and prostacyclin release during reperfusion
  73. Effect of endothelins on the cardiovascular system
  74. Morphological characterization of GFP stably transfected adult mesenchymal bone marrow stem cells
  75. Myocardial protection from ischemic preconditioning is not blocked by sub-chronic inhibition of carnitine palmitoyltransferase I
  76. Rethinking the Renin-Angiotensin System and Its Role in Cardiovascular Regulation
  77. Haemodynamic responses following intermittent supramaximal exercise in athletes
  78. The anti-inflammatory agents Siblings Nitroxyl (HNO) and Nitric Oxide (NO) in Cardioprotection
  79. Differential biological effects of products of nitric oxide (NO) synthase: it is not enough to say NO
  80. Comparison between the effects of pentobarbital or ketamine/nitrous oxide anesthesia on metabolic and endothelial components of coronary reactive hyperemia
  81. Ischemic preconditioning
  82. Specificity of synergistic coronary flow enhancement by adenosine and pulsatile perfusion in the dog
  83. The effects of ischemic preconditioning on resting coronary flow and reactive hyperemia: Involvement of A1 adenosine receptors
  84. The Gaboon viper, Bitis gabonica: Hemorrhagic, metabolic, cardiovascular and clinical effects of the venom
  85. Myocardial, neural and vascular aspects of ischemic preconditioning
  86. The effect of the inhibition of the endothelial release of nitric oxide on coronary reactive hyperaemia in the anaesthetized dog